trending Market Intelligence /marketintelligence/en/news-insights/trending/82eGyZwX55dYJoX-SmsM7A2 content esgSubNav
In This List

Tandem Diabetes plans common stock, warrants offering

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Tandem Diabetes plans common stock, warrants offering

Tandem Diabetes Care Inc. plans to offer and sell its common shares, series A warrants and series B warrants to buy common shares in an underwritten public offering.

The company plans to use the net proceeds for working capital and other general corporate purposes.

Oppenheimer & Co. Inc. is acting as the sole book-running manager and National Securities Corp. is acting as a co-manager for the offering.